We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-After 4.2 million COVID-19 cases in November, U.S. pins hope on vaccine

Tue, 01st Dec 2020 15:16

(Adds Ohio governor, travel data)

WASHINGTON, Dec 1 (Reuters) - The United States entered the
final month of the year with expectations that promising vaccine
candidates will soon be approved to halt the rapidly spreading
coronavirus after 4.2 million new cases were reported in
November.

The new COVID-19 cases were more than double the previous
monthly record set in October, as large numbers of Americans
still refuse to wear masks and continue to gather in holiday
crowds, against the recommendations of experts.

With outgoing President Donald Trump's coronavirus strategy
relying heavily on a vaccine, a Food and Drug Administration
panel of outside advisers will meet on Dec. 10 to discuss
whether to recommend that the FDA authorize emergency use of a
vaccine developed by Pfizer Inc.

The advisers will consider a second candidate, from Moderna
Inc, a week later, officials have said, raising hopes
that Americans could start receiving inoculations before the end
of the year, although it could take months to vaccinate people
widely across the country.

Other global pharmaceutical companies, including AstraZeneca
PLC and Johnson & Johnson also have vaccines in
the works, leading a member of the Trump administration's
"Operation Warp Speed" program to predict the country could be
vaccinated by June.

"One hundred percent of the Americans that want the vaccine
will have the vaccine by (June). We will have over 300 million
doses available to the American public well before then," Paul
Ostrowski, the vaccine program's director of supply, production
and distribution, told MSNBC television on Monday.

Ohio Governor Mike DeWine said officials in his state have
identified 10 hospitals that will receive the first doses of
vaccine, which he said should arrive around Dec. 15.

In the next several days, the state will inform the federal
government of other places where the shipments should be made,
he said. DeWine, interviewed on CBS' "This Morning" show on
Tuesday, added that the National Guard might get involved in
moving vaccines out to smaller counties.

First responders, nurses and doctors will be first in line
for the vaccines, as well as nursing home patients, he said.

"That December 15 date just can't come soon enough. We're
very excited about it and very happy about it," DeWine said

In the meantime, leading health officials are pleading with
Americans to follow their recommendations and help arrest a
pandemic that killed more than 36,000 people in November,
pushing hospitalizations to a record high of nearly 93,000 on
Sunday, according to a Reuters tally.

The widespread impact of the outbreak has led
Merriam-Webster to choose "pandemic" as the Word of the Year
after it racked up the most online dictionary lookups of any
word.

With more than 10,000 people dying and 1.1 million
contracting the coronavirus in the week ended Sunday, Republican
Trump has remained focused on overturning the results of the
Nov. 3 election won by Democratic President-elect Joe Biden,
denying Trump a second term.

Biden has pledged to make combating the coronavirus his top
priority upon taking office on Jan. 20, saying he will rely on
the best scientific evidence.

Millions of Americans defied experts' advice and traveled
over the Thanksgiving holiday weekend, traditionally one of the
busiest periods of the year in the United States for flying.

The number of travelers passing through U.S. airports
reached 981,912 on Monday, down from 1.18 million on Sunday,
which marked the most since government restrictions began to
sharply depress travel in March, the Transportation Security
Administration said.

Both days' travel figures were less than half of their
year-ago levels, the TSA said.

(Reporting by Reuters staff; Writing by Daniel Trotta; Editing
by Bernadette Baum and Jonathan Oatis)

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.